You are here
Erythropoiesis-Stimulating Agents in the Treatment of Anaemia in Cancer Patients: ESMO Clinical Practice Guidelines
D. Schrijvers, H. De Samblanx, F. Roila
Annals of Oncology 2010; 21(Supplement 5): v244–v247
Anaemia is defined as a reduction of the haemoglobin (Hb) concentration, red-cell count or packed cell volume below normal levels. Mild anaemia is defined as an Hb of ≤11.9 g/dl and ≥10 g/dl, moderate anaemia as an Hb of ≤9.9 and ≥8.0 g/dl and severe anaemia as an Hb of <8.0 g/dl.